- Gennova partners with CEPI to develop saRNA vaccine for Nipah virus financialexpress.com
- Gennova, CEPI ink pact to develop AI-enhanced Nipah vaccine with $13.4 million funding Moneycontrol
- Pune-based Gennova Biopharmaceuticals secures US$ 13.38 million funding to develop Nipah virus vaccine The Indian Express
- AI-enhanced self-amplifying mRNA vaccine set to combat one of the deadliest known viruses CEPI
- Emcure Pharma arm Gennova advances development of Nipah virus vaccine Medical Dialogues
Gennova partners with CEPI to develop saRNA vaccine for Nipah virus financialexpress.comGennova, CEPI ink pact to develop AI-enhanced Nipah vaccine with $13.4 million funding MoneycontrolPune-based Gennova Biopharmaceuticals secures US$ 13.38 million funding to develop Nipah virus vaccine The Indian ExpressAI-enhanced self-amplifying mRNA vaccine set to combat one of the deadliest known viruses CEPIEmcure Pharma arm Gennova advances development of Nipah virus vaccine Medical Dialogues Top stories – Google News